story of the week
Sacituzumab Govitecan in Previously Treated Hormone Receptor–Positive/HER2-Negative Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sacituzumab Govitecan in Previously Treated Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Final Results From a Phase I/II, Single-Arm, Basket Trial
Ann. Oncol 2020 Dec 01;31(12)1709-1718, K Kalinsky, JR Diamond, LT Vahdat, SM Tolaney, D Juric, J O'Shaughnessy, RL Moroose, IA Mayer, VG Abramson, DM Goldenberg, RM Sharkey, P Maliakal, Q Hong, T Goswami, WA Wegener, A BardiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.